BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25792709)

  • 1. Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.
    Gougelet A; Sartor C; Bachelot L; Godard C; Marchiol C; Renault G; Tores F; Nitschke P; Cavard C; Terris B; Perret C; Colnot S
    Gut; 2016 Jun; 65(6):1024-34. PubMed ID: 25792709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
    Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP
    J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-34a screened by miRNA profiling negatively regulates Wnt/β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity.
    Zhu L; Gao J; Huang K; Luo Y; Zhang B; Xu W
    Sci Rep; 2015 Nov; 5():16732. PubMed ID: 26567713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital.
    Sidaway JE; Orton TC; Kalaitzi K; Jones HB; Foster A; Lake BG
    Toxicology; 2020 Jan; 430():152343. PubMed ID: 31836555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer.
    Siemens H; Neumann J; Jackstadt R; Mansmann U; Horst D; Kirchner T; Hermeking H
    Clin Cancer Res; 2013 Feb; 19(3):710-20. PubMed ID: 23243217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesis.
    Schaeffer S; Gupta B; Calatayud AL; Calderaro J; Caruso S; Hirsch TZ; Pelletier L; Zucman-Rossi J; Rebouissou S
    J Hepatol; 2023 Sep; 79(3):704-716. PubMed ID: 37201672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the diagnostic and therapeutic roles of non-coding RNA and cell proliferation related gene association in hepatocellular carcinoma.
    Ahmed MY; Salah MM; Kassim SK; Abdelaal A; Elayat WM; Mohamed DA; Fouly AE; Abu-Zahra FAE
    Gene; 2019 Jul; 706():97-105. PubMed ID: 31034943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
    Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
    Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis.
    Patil MA; Lee SA; Macias E; Lam ET; Xu C; Jones KD; Ho C; Rodriguez-Puebla M; Chen X
    Cancer Res; 2009 Jan; 69(1):253-61. PubMed ID: 19118010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice.
    Anna CH; Iida M; Sills RC; Devereux TR
    Toxicol Appl Pharmacol; 2003 Jul; 190(2):135-45. PubMed ID: 12878043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
    Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
    Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway.
    Lu C; Jia S; Zhao S; Shao X
    Cancer Biomark; 2019; 25(1):115-126. PubMed ID: 31006667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.